Aeterna Zentaris
AEZS
#10198
Rank
โ‚ฌ15.04 M
Marketcap
4,91ย โ‚ฌ
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Earnings for Aeterna Zentaris (AEZS)

Earnings in 2024 (TTM): -โ‚ฌ5.08 Million

According to Aeterna Zentaris's latest financial reports the company's current earnings are โ‚ฌ6.32 Million. In 2023 the company made an earning of -โ‚ฌ2.88 Million a decrease over its 2022 earnings that were of โ‚ฌ3.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aeterna Zentaris from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ5.08 Million76.46%
2023 -โ‚ฌ2.88 Million-193.05%
2022 โ‚ฌ3.08 M118.42%
2021 โ‚ฌ1.41 M66.11%
2020 โ‚ฌ0.85 M-251.06%
2019 -โ‚ฌ0.57 Million25.51%
2018 -โ‚ฌ0.45 Million72.53%
2017 -โ‚ฌ0.27 Million-109.78%
2016 โ‚ฌ2.66 M49.97%
2015 โ‚ฌ1.77 M61.77%
2014 โ‚ฌ1.09 M597.94%
2013 โ‚ฌ0.15 M-134.11%
2012 -โ‚ฌ0.47 Million-182.25%
2011 โ‚ฌ0.56 M-50.2%
2010 โ‚ฌ1.12 M1084.23%
2009 โ‚ฌ0.09 M-109.18%
2008 -โ‚ฌ1.04 Million-6.23%
2007 -โ‚ฌ1.11 Million752.47%
2006 -โ‚ฌ0.13 Million269.03%
2005 -โ‚ฌ0.04 Million-84.64%
2004 -โ‚ฌ0.23 Million9.96%
2003 -โ‚ฌ0.21 Million184.21%
2002 -โ‚ฌ0.08 Million-69.93%
2001 -โ‚ฌ0.25 Million-22.76%
2000 -โ‚ฌ0.32 Million-13.94%
1999 -โ‚ฌ0.37 Million-31.33%
1998 -โ‚ฌ0.54 Million-84.12%
1997 -โ‚ฌ3.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ53.15 Million 1,028.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.10 B-299,416.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B-146,540.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.81 B-165,996.94%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
โ‚ฌ0.64 B-13,698.38%๐Ÿ‡บ๐Ÿ‡ธ USA